Virgen del Rocío University Hospital, Seville Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2018
NCT03985722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hospital Virgen del Rocío | Hospital Virgen del Rocío, Seville | Virgen del Rocío University Hospital | Virgen del Rocío University Hospital Research and Clinical Trials Unit

Active Ingredients

Drugs in Phase 4 Trials (2)

fluticasone (cutivate) (1 trial)

formoterol (foradil) (1 trial)

Drugs in Phase 2 Trials (3)

biotin (1 trial)

olive (1 trial)

thiamine (1 trial)

Drugs in Phase 1 Trials (2)

olaratumab (lartruvo) (1 trial)

trabectedin (yondelis) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Sarcoma (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7